|
|
|
 |
 Congress at a Glance |
|
Scientific Programme
|
|
Satellite Programme
|
|
Maps of the Venue
|
|
 |
|
|
|
|
|
|
|
|
|
|
 |
 |
|
|
|
| 14:00-16:05
|
|
S.13:
 Treatment track
Breaking News 2 |
|
| Chairs: |
René S. Kahn, The Netherlands |
| |
Daniel Souery, Belgium |
|
|
|
|
| 14:00 |
|
|
S.13.01
Elevated striatal dopamine function is related to altered prefrontal activation in people with prodromal signs
|
|
|
Philip K. McGuire, United Kingdom
|
|
|
|
| 14:25 |
|
|
S.13.02
Subcallosal cingulate gyrus deep brain stimulation in 20 patients with treatment resistant depression
|
|
|
Andres M. Lozano, Canada
|
|
|
|
| 14:50 |
|
|
S.13.03
Abnormal regional brain serotonin function in remitted depression revealed using citalopram challenge pharmacoMRI
|
|
|
Danilo Arnone, United Kingdom
|
|
|
|
| 15:15 |
|
|
S.13.04
Erythropoietin reduces negative biases in biomarker models of antidepressant drug action in depressed patients
|
|
|
Kamilla Miskowiak, Denmark
|
|
|
|
| 15:40 |
|
|
S.13.05
Ecstasy and sociability: an fMRI study of social reward and social threat after MDMA (ecstasy) in humans
|
|
|
Gillinder Bedi, USA
|
|
|
|
| 14:00-16:05
|
|
S.14:
 Clinical research track
Neuroimaging and psychosis - current trends |
|
| Chairs: |
Martha Shenton, USA |
| |
Mark Weiser, Israel |
|
|
|
|
| 14:50 |
|
|
S.14.03
Patterns of gyrification in individuals at risk for psychosis
|
|
|
Kai Vogeley, Germany
|
| Kai Vogeley, Germany will be replaced by Stephan Rurhmann, Germany |
|
|
| 15:40 |
|
|
S.14.05
Glutamate, dopamine and psychosis: an update
|
|
|
Marc Laruelle, United Kingdom
|
|
|
|
| 14:00-16:05
|
|
S.15:
 Interface track
CCNP symposium - Maternal stress and the health of the offspring: from bench to bedside |
|
| Chairs: |
Michael Meaney, Canada |
| |
Meir Steiner, Canada |
|
|
|
|
| 14:00 |
|
|
S.15.01
Maternal care sculpts the epigenome of the offspring
|
|
|
Michael Meaney, Canada
|
|
|
|
| 14:25 |
|
|
S.15.02
Maternal adversity and glucocorticoids program: endocrine function and behaviour across generations
|
|
|
Stephen Matthews, Canada
|
|
|
|
| 14:00-16:05
|
|
S.16:
 Preclinical track
TEM symposium - Neurogenesis and stem cell |
|
| Chairs: |
Eero Castrén, Finland |
| |
Marie-Hélène Thiébot, France |
|
|
|
|
| 15:40 |
|
|
S.16.05
Stem cell strategies for Parkinson's disease
|
|
|
Ernest Arenas, Sweden
|
|
|
|
|
|
|
Treatment
track
Clinical
research track
Interface
track
Preclinical
track
Educational updates
track